SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Getting a moderate amount of healthy exercise can also help protect against cognitive decline, as does eating well and ...

Cognitive impairment is a recognized sequela of the demyelinating disorder multiple sclerosis (MS). Various studies have ...

While there's currently no cure for multiple sclerosis, a lot of new treatment options have become available—many in just the ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...

Every day, I see how unnecessary delays in treatment caused by cumbersome prior authorization barriers affect my patients.

Reports show nearly one million people in the United States have multiple sclerosis (MS). For those unfamiliar, the disease ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on th | Immunology ...

Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...

Multiple Sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath.

Anti-CD20 therapies like Ocrevus and rituximab may be ineffective at slowing disability progression in PPMS patients, per a ...